Hepatectomy

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research

Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy

Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases

Neoadjuvant Anti-PD1 in HCC

A Novel MSE Score to Predict rHCC Patients

Hepatectomy for Early-stage HCC Patients With CSPH

Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.

Effect of the Laparoscopic Approach in Reducing Postoperative Severe Complications Following Hepatectomy for Colorectal Liver Metastases

The Major Bleeding Risk Following Hepatectomy

Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging

Surgical Management of Giant Hepatic Hemangioma

The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment

Surgery for Recurrent Intrahepatic Cholangiocarcinoma

The Role of Tumor-associated Macrophages in Colorectal Liver Metastases

Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma

Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma

Combined HCC-MFCCC

Hepatectomy With or Without the Thoraco-abdominal Approach